227 related articles for article (PubMed ID: 10728961)
1. Clinical and cost comparison of ibutilide and direct-current cardioversion for atrial fibrillation and flutter.
Murdock DK; Schumock GT; Kaliebe J; Olson K; Guenette AJ
Am J Cardiol; 2000 Feb; 85(4):503-6, A11. PubMed ID: 10728961
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm.
Zarkin GA; Bala MV; Calingaert B; VanderLugt JT
Am J Manag Care; 1997 Sep; 3(9):1387-94. PubMed ID: 10178487
[TBL] [Abstract][Full Text] [Related]
3. Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department.
Vinson DR; Lugovskaya N; Warton EM; Rome AM; Stevenson MD; Reed ME; Nagam MR; Ballard DW;
Ann Emerg Med; 2018 Jan; 71(1):96-108.e2. PubMed ID: 28969929
[TBL] [Abstract][Full Text] [Related]
4. Cost analysis of transthoracic cardioversion of atrial fibrillation with and without ibutilide pretreatment.
Oral H; Knight BP; Sticherling C; Kim MH; Baker RL; Chough SP; Wasmer K; Pelosi F; Michaud GF; Fendrick AM; Strickberger SA; Morady F
J Cardiovasc Pharmacol Ther; 2000 Oct; 5(4):259-66. PubMed ID: 11150395
[TBL] [Abstract][Full Text] [Related]
5. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
[TBL] [Abstract][Full Text] [Related]
6. Termination of recent-onset atrial fibrillation/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion.
Domanovits H; Schillinger M; Thoennissen J; Nikfardjam M; Janata K; Brunner M; Laggner AN
Resuscitation; 2000 Aug; 45(3):181-7. PubMed ID: 10959017
[TBL] [Abstract][Full Text] [Related]
7. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
Volgman AS; Carberry PA; Stambler B; Lewis WR; Dunn GH; Perry KT; Vanderlugt JT; Kowey PR
J Am Coll Cardiol; 1998 May; 31(6):1414-9. PubMed ID: 9581743
[TBL] [Abstract][Full Text] [Related]
8. Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients: Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter.
Malviya A; Kapoor M; Sivam RKN; Khan SA; Pandey R; Kumar U; Ete T; Mishra A
Indian Heart J; 2020; 72(4):283-288. PubMed ID: 32861384
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation.
Coleman CI; Kalus JS; White CM; Spencer AP; Tsikouris JP; Chung JO; Kenyon KW; Ziska M; Kluger J; Reddy P
Pharmacoeconomics; 2004; 22(13):877-83. PubMed ID: 15329032
[TBL] [Abstract][Full Text] [Related]
10. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
Naegeli B; Straumann E; Bertel O
Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of digoxin, pacing, and direct current cardioversion for conversion of atrial flutter in neonates.
Prasad D; Steinberg J; Snyder C
Cardiol Young; 2018 May; 28(5):725-729. PubMed ID: 29506589
[TBL] [Abstract][Full Text] [Related]
12. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing.
Stambler BS; Wood MA; Ellenbogen KA
Am J Cardiol; 1996 May; 77(11):960-6. PubMed ID: 8644646
[TBL] [Abstract][Full Text] [Related]
14. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
Glatter K; Yang Y; Chatterjee K; Modin G; Cheng J; Kayser S; Scheinman MM
Circulation; 2001 Jan; 103(2):253-7. PubMed ID: 11208685
[TBL] [Abstract][Full Text] [Related]
15. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
[TBL] [Abstract][Full Text] [Related]
17. Use of ibutilide for cardioversion of recent-onset atrial fibrillation and flutter in elderly.
Gowda RM; Khan IA; Punukollu G; Mendoza C; Wilbur SL; Vasavada BC; Sacchi TJ
Am J Ther; 2004; 11(2):95-7. PubMed ID: 14999360
[TBL] [Abstract][Full Text] [Related]
18. Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset.
Reisinger J; Gatterer E; Lang W; Vanicek T; Eisserer G; Bachleitner T; Niemeth C; Aicher F; Grander W; Heinze G; Kühn P; Siostrzonek P
Eur Heart J; 2004 Aug; 25(15):1318-24. PubMed ID: 15288159
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: a reanalysis with recently acquired data.
Arnar DO; Danielsen R
Cardiology; 1996; 87(3):181-8. PubMed ID: 8725311
[TBL] [Abstract][Full Text] [Related]
20. Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide?
Varriale P; Sedighi A
Clin Cardiol; 2000 Apr; 23(4):265-8. PubMed ID: 10763074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
